FDA Framework For Personalized Therapies Raises Questions
By Joshua Oyster, Beth Weinman and Austin Laroche · March 20, 2026, 6:06 PM EDT
On Feb. 23, the U.S. Food and Drug Administration issued a highly anticipated draft guidance that details a new regulatory approach — the plausible mechanism framework — for the development of...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login